Literature DB >> 15253696

Endothelial injury and dysfunction: role in the extension phase of acute renal failure.

Bruce A Molitoris1, Timothy A Sutton.   

Abstract

The pathophysiology of ischemic acute renal failure (ARF) involves a complex interplay between renal hemodynamics, tubular and endothelial cell injury, and inflammatory processes. A growing body of evidence supports the contribution of altered renal vascular function, especially at the microvascular level, in initiating and subsequently extending the initial tubular injury. The extension phase of ischemic ARF involves continued reduction in renal perfusion, ongoing hypoxia, and inflammatory processes that occur during reperfusion and contribute to continued tubular cell injury. Vascular endothelial cell injury and dysfunction play a vital part in this extension phase. With injury, the endothelial cell loses its ability to regulate vascular tone, perfusion, permeability and inflammation/adhesion. This loss of regulatory function has a detrimental impact upon renal function. Vascular congestion, edema formation, diminished blood flow, and infiltration of inflammatory cells have been documented in the corticomedullary junction of the kidney. However, linking their genesis to microvascular endothelial injury and dysfunction has been difficult. New diagnostic and therapeutic approaches to ischemic ARF must incorporate these finding to devise early recognition strategies and therapeutic approaches.

Entities:  

Mesh:

Year:  2004        PMID: 15253696     DOI: 10.1111/j.1523-1755.2004.761_5.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  111 in total

1.  Role of circulating fibroblast growth factor-2 in lipopolysaccharide-induced acute kidney injury in mice.

Authors:  Parnell C Mattison; Angel A Soler-García; Jharna R Das; Marina Jerebtsova; Sofia Perazzo; Pingtao Tang; Patricio E Ray
Journal:  Pediatr Nephrol       Date:  2011-09-30       Impact factor: 3.714

2.  Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1.

Authors:  Jong-Sup Bae; In-San Kim; Alireza R Rezaie
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

3.  Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Authors:  Martin Matejovic; Can Ince; Lakhmir S Chawla; Roland Blantz; Bruce A Molitoris; Mitchell H Rosner; Mark D Okusa; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-28       Impact factor: 10.121

4.  Renal-targeting triptolide-glucosamine conjugate exhibits lower toxicity and superior efficacy in attenuation of ischemia/reperfusion renal injury in rats.

Authors:  Yu Fu; Qing Lin; Tao Gong; Xun Sun; Zhi-Rong Zhang
Journal:  Acta Pharmacol Sin       Date:  2016-07-11       Impact factor: 6.150

5.  Endothelial health and diversity in the kidney.

Authors:  Mark S Segal; Chris Baylis; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2006-02       Impact factor: 10.121

6.  Arginase-2 mediates renal ischemia-reperfusion injury.

Authors:  Wesley M Raup-Konsavage; Ting Gao; Timothy K Cooper; Sidney M Morris; W Brian Reeves; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

7.  Soluble thrombomodulin protects ischemic kidneys.

Authors:  Asif A Sharfuddin; Ruben M Sandoval; David T Berg; Grant E McDougal; Silvia B Campos; Carrie L Phillips; Bryan E Jones; Akanksha Gupta; Brian W Grinnell; Bruce A Molitoris
Journal:  J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 10.121

Review 8.  Urinary biomarkers of kidney diseases in HIV-infected children.

Authors:  Sofia Perazzo; Ángel A Soler-García; Yetrib Hathout; Jharna R Das; Patricio E Ray
Journal:  Proteomics Clin Appl       Date:  2015-06       Impact factor: 3.494

Review 9.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

10.  Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.

Authors:  F Favreau; R Thuillier; J Cau; S Milin; E Manguy; G Mauco; X Zhu; L O Lerman; T Hauet
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.